Share Price and Basic Stock Data
Last Updated: November 6, 2025, 8:16 pm
| PEG Ratio | -3.54 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
AVT Natural Products Ltd operates in the agricultural products sector and has shown a fluctuating revenue trend over recent quarters. As of June 2023, the company reported sales of ₹103 Cr, which rose to ₹135 Cr in September 2023, before reaching ₹154 Cr in December 2023. However, there was a decline to ₹125 Cr in March 2024, followed by a further decrease to ₹105 Cr in June 2024. For the fiscal year ending March 2025, the total sales stood at ₹556 Cr, a decline from ₹582 Cr reported in March 2023. The trailing twelve months (TTM) sales reported were ₹584 Cr. The revenue from operations per share increased to ₹36.51 in March 2025 from ₹33.97 in March 2024. This indicates a growing operational scale, though the overall annual revenue performance reflects some volatility that may need addressing for sustainable growth.
Profitability and Efficiency Metrics
AVT Natural Products Ltd’s profitability metrics demonstrate a mixed performance. The net profit for the fiscal year ending March 2025 was ₹48 Cr, a decline from ₹77 Cr in the previous fiscal year. The earnings per share (EPS) stood at ₹3.17 for March 2025, down from ₹5.08 in March 2023. The operating profit margin (OPM) for the same period was reported at 13%, indicating a decrease from 21% in March 2023, highlighting potential cost management challenges. The interest coverage ratio (ICR) was strong at 9.11x, suggesting that the company can comfortably meet its interest obligations. However, the return on equity (ROE) was recorded at 9.52%, below the typical sector range, reflecting less effective equity utilization. With the cash conversion cycle (CCC) at 388 days, operational efficiency requires improvement, especially in managing inventory and receivables.
Balance Sheet Strength and Financial Ratios
As of March 2025, AVT Natural Products Ltd exhibited a solid balance sheet, with total assets amounting to ₹747 Cr and total liabilities at ₹747 Cr, indicating a balanced capital structure. The company’s reserves increased to ₹491 Cr from ₹415 Cr in the previous year, highlighting retained earnings and potential reinvestment. Borrowings rose significantly to ₹113 Cr from ₹37 Cr, which may raise concerns about financial leverage. The debt-to-equity ratio stood at 0.21, suggesting a low level of debt relative to equity, which is favorable. The current ratio was reported at 2.90, indicating strong short-term liquidity. However, the return on capital employed (ROCE) decreased to 14% from 24.68% in March 2023, raising questions about the efficiency of capital utilization in generating profits.
Shareholding Pattern and Investor Confidence
The shareholding pattern of AVT Natural Products Ltd reflects strong promoter confidence, with promoters holding 75% of the total shares. Institutional investors, including foreign institutional investors (FIIs) and domestic institutional investors (DIIs), have minimal stakes at 0.06% and 0.11%, respectively. This low institutional presence may indicate a lack of confidence or interest from larger investors, which could affect stock liquidity and market perception. The number of shareholders increased significantly from 39,157 in June 2023 to 52,207 in June 2025, suggesting growing retail investor interest. However, the declining net profit and volatility in revenue may cause concern among existing and potential investors. The company must enhance its fundamentals to attract a broader institutional base and reassure retail investors.
Outlook, Risks, and Final Insight
AVT Natural Products Ltd faces several strengths and risks moving forward. Strengths include a strong promoter holding, robust interest coverage, and increasing reserves, which position the company well for future growth. However, risks such as declining profitability, high cash conversion cycle, and rising borrowings could hinder operational efficiency and financial stability. The company may need to focus on optimizing its operational processes and managing costs effectively to improve margins. The outlook can be positive if management addresses these operational challenges while leveraging its strong equity base. Alternatively, failure to manage costs and improve sales could lead to further declines in profitability and investor confidence, necessitating strategic repositioning or operational restructuring to maintain market competitiveness.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of AVT Natural Products Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| GRM Overseas Ltd | 2,715 Cr. | 443 | 447/176 | 53.0 | 65.3 | 0.00 % | 12.1 % | 14.6 % | 2.00 |
| Freshtrop Fruits Ltd | 121 Cr. | 152 | 175/105 | 141 | 0.00 % | 6.12 % | 5.36 % | 10.0 | |
| City Crops Agro Ltd | 33.4 Cr. | 20.5 | 30.4/17.0 | 13.5 | 19.4 | 0.00 % | 8.46 % | 8.14 % | 10.0 |
| Chamanlal Setia Exports Ltd | 1,342 Cr. | 270 | 447/243 | 13.2 | 147 | 0.92 % | 16.7 % | 14.2 % | 2.00 |
| Mangalam Global Enterprise Ltd | 472 Cr. | 14.4 | 18.5/10.6 | 18.1 | 6.86 | 0.07 % | 16.8 % | 14.6 % | 1.00 |
| Industry Average | 3,472.82 Cr | 270.97 | 26.24 | 106.37 | 0.32% | 11.71% | 12.10% | 4.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 149 | 160 | 139 | 134 | 103 | 135 | 154 | 125 | 105 | 122 | 173 | 157 | 132 |
| Expenses | 113 | 126 | 112 | 110 | 92 | 119 | 118 | 109 | 97 | 114 | 143 | 132 | 117 |
| Operating Profit | 36 | 34 | 27 | 24 | 11 | 17 | 36 | 16 | 8 | 8 | 30 | 25 | 16 |
| OPM % | 24% | 21% | 19% | 18% | 11% | 12% | 23% | 13% | 8% | 7% | 17% | 16% | 12% |
| Other Income | 1 | 3 | -1 | -1 | 3 | 5 | -0 | 5 | 5 | 5 | 4 | 2 | 4 |
| Interest | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 2 | 1 | 2 | 3 | 3 | 2 |
| Depreciation | 3 | 3 | 4 | 4 | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 3 |
| Profit before tax | 33 | 33 | 20 | 18 | 10 | 16 | 30 | 15 | 8 | 8 | 28 | 20 | 15 |
| Tax % | 25% | 25% | 34% | 21% | 19% | 27% | 26% | 26% | 25% | 17% | 23% | 27% | 18% |
| Net Profit | 25 | 25 | 13 | 14 | 8 | 12 | 22 | 11 | 6 | 6 | 22 | 14 | 12 |
| EPS in Rs | 1.63 | 1.64 | 0.88 | 0.93 | 0.55 | 0.76 | 1.47 | 0.72 | 0.39 | 0.41 | 1.42 | 0.94 | 0.80 |
Last Updated: August 20, 2025, 1:15 pm
Below is a detailed analysis of the quarterly data for AVT Natural Products Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 132.00 Cr.. The value appears to be declining and may need further review. It has decreased from 157.00 Cr. (Mar 2025) to 132.00 Cr., marking a decrease of 25.00 Cr..
- For Expenses, as of Jun 2025, the value is 117.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 132.00 Cr. (Mar 2025) to 117.00 Cr., marking a decrease of 15.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 25.00 Cr. (Mar 2025) to 16.00 Cr., marking a decrease of 9.00 Cr..
- For OPM %, as of Jun 2025, the value is 12.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Mar 2025) to 12.00%, marking a decrease of 4.00%.
- For Other Income, as of Jun 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2025) to 4.00 Cr., marking an increase of 2.00 Cr..
- For Interest, as of Jun 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20.00 Cr. (Mar 2025) to 15.00 Cr., marking a decrease of 5.00 Cr..
- For Tax %, as of Jun 2025, the value is 18.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 18.00%, marking a decrease of 9.00%.
- For Net Profit, as of Jun 2025, the value is 12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 14.00 Cr. (Mar 2025) to 12.00 Cr., marking a decrease of 2.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.80. The value appears to be declining and may need further review. It has decreased from 0.94 (Mar 2025) to 0.80, marking a decrease of 0.14.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 22, 2025, 5:26 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 290 | 261 | 274 | 311 | 328 | 339 | 396 | 485 | 559 | 582 | 517 | 556 | 584 |
| Expenses | 216 | 214 | 235 | 269 | 295 | 297 | 339 | 414 | 454 | 461 | 438 | 486 | 506 |
| Operating Profit | 74 | 48 | 39 | 42 | 33 | 42 | 57 | 71 | 106 | 121 | 79 | 70 | 78 |
| OPM % | 25% | 18% | 14% | 14% | 10% | 12% | 14% | 15% | 19% | 21% | 15% | 13% | 13% |
| Other Income | 1 | 2 | 1 | 5 | 13 | 4 | 7 | 8 | 10 | 2 | 13 | 16 | 15 |
| Interest | 2 | 4 | 1 | 2 | 3 | 5 | 6 | 4 | 5 | 5 | 7 | 9 | 10 |
| Depreciation | 5 | 6 | 6 | 7 | 7 | 11 | 14 | 15 | 14 | 13 | 14 | 14 | 13 |
| Profit before tax | 67 | 41 | 33 | 38 | 36 | 30 | 45 | 61 | 97 | 105 | 71 | 63 | 70 |
| Tax % | 37% | 35% | 35% | 36% | 32% | 30% | 24% | 25% | 25% | 26% | 25% | 24% | |
| Net Profit | 42 | 26 | 22 | 24 | 24 | 21 | 34 | 45 | 73 | 77 | 53 | 48 | 54 |
| EPS in Rs | 2.76 | 1.73 | 1.42 | 1.61 | 1.59 | 1.37 | 2.23 | 2.97 | 4.78 | 5.08 | 3.50 | 3.17 | 3.57 |
| Dividend Payout % | 27% | 29% | 28% | 25% | 25% | 29% | 27% | 24% | 21% | 20% | 23% | 25% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -38.10% | -15.38% | 9.09% | 0.00% | -12.50% | 61.90% | 32.35% | 62.22% | 5.48% | -31.17% | -9.43% |
| Change in YoY Net Profit Growth (%) | 0.00% | 22.71% | 24.48% | -9.09% | -12.50% | 74.40% | -29.55% | 29.87% | -56.74% | -36.65% | 21.73% |
AVT Natural Products Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 7% |
| 3 Years: | 0% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 7% |
| 3 Years: | -13% |
| TTM: | 7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 12% |
| 3 Years: | -12% |
| 1 Year: | -18% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 15% |
| 3 Years: | 13% |
| Last Year: | 10% |
Last Updated: September 5, 2025, 12:10 am
Balance Sheet
Last Updated: June 16, 2025, 12:26 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 152 | 171 | 185 | 209 | 223 | 236 | 260 | 295 | 354 | 415 | 454 | 491 |
| Borrowings | 5 | 7 | 10 | 15 | 36 | 81 | 46 | 54 | 25 | 37 | 43 | 113 |
| Other Liabilities | 64 | 44 | 39 | 36 | 55 | 56 | 57 | 62 | 55 | 56 | 86 | 128 |
| Total Liabilities | 237 | 237 | 249 | 275 | 330 | 389 | 378 | 426 | 449 | 524 | 598 | 747 |
| Fixed Assets | 51 | 53 | 58 | 57 | 56 | 98 | 99 | 89 | 82 | 78 | 82 | 72 |
| CWIP | 0 | 2 | 1 | 0 | 28 | 0 | 0 | 0 | 2 | 0 | 0 | 4 |
| Investments | 15 | 7 | 28 | 38 | 30 | 7 | 8 | 8 | 28 | 58 | 127 | 136 |
| Other Assets | 171 | 175 | 162 | 180 | 215 | 283 | 271 | 329 | 337 | 387 | 390 | 535 |
| Total Assets | 237 | 237 | 249 | 275 | 330 | 389 | 378 | 426 | 449 | 524 | 598 | 747 |
Below is a detailed analysis of the balance sheet data for AVT Natural Products Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 15.00 Cr..
- For Reserves, as of Mar 2025, the value is 491.00 Cr.. The value appears strong and on an upward trend. It has increased from 454.00 Cr. (Mar 2024) to 491.00 Cr., marking an increase of 37.00 Cr..
- For Borrowings, as of Mar 2025, the value is 113.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 43.00 Cr. (Mar 2024) to 113.00 Cr., marking an increase of 70.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 128.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 86.00 Cr. (Mar 2024) to 128.00 Cr., marking an increase of 42.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 747.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 598.00 Cr. (Mar 2024) to 747.00 Cr., marking an increase of 149.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 72.00 Cr.. The value appears to be declining and may need further review. It has decreased from 82.00 Cr. (Mar 2024) to 72.00 Cr., marking a decrease of 10.00 Cr..
- For CWIP, as of Mar 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 4.00 Cr., marking an increase of 4.00 Cr..
- For Investments, as of Mar 2025, the value is 136.00 Cr.. The value appears strong and on an upward trend. It has increased from 127.00 Cr. (Mar 2024) to 136.00 Cr., marking an increase of 9.00 Cr..
- For Other Assets, as of Mar 2025, the value is 535.00 Cr.. The value appears strong and on an upward trend. It has increased from 390.00 Cr. (Mar 2024) to 535.00 Cr., marking an increase of 145.00 Cr..
- For Total Assets, as of Mar 2025, the value is 747.00 Cr.. The value appears strong and on an upward trend. It has increased from 598.00 Cr. (Mar 2024) to 747.00 Cr., marking an increase of 149.00 Cr..
Notably, the Reserves (491.00 Cr.) exceed the Borrowings (113.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 69.00 | 41.00 | 29.00 | 27.00 | -3.00 | -39.00 | 11.00 | 17.00 | 81.00 | 84.00 | 36.00 | -43.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 47 | 58 | 69 | 65 | 71 | 88 | 69 | 77 | 67 | 76 | 78 | 103 |
| Inventory Days | 248 | 278 | 184 | 205 | 186 | 341 | 235 | 258 | 263 | 342 | 365 | 431 |
| Days Payable | 59 | 37 | 28 | 39 | 68 | 82 | 43 | 59 | 45 | 44 | 98 | 146 |
| Cash Conversion Cycle | 236 | 300 | 226 | 231 | 188 | 347 | 261 | 275 | 284 | 373 | 345 | 388 |
| Working Capital Days | 114 | 159 | 143 | 119 | 116 | 166 | 151 | 159 | 163 | 176 | 171 | 172 |
| ROCE % | 40% | 25% | 17% | 17% | 14% | 11% | 15% | 19% | 27% | 26% | 16% | 13% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 3.17 | 3.50 | 5.08 | 4.78 | 2.97 |
| Diluted EPS (Rs.) | 3.17 | 3.50 | 5.08 | 4.78 | 2.97 |
| Cash EPS (Rs.) | 4.08 | 4.41 | 5.96 | 5.73 | 3.97 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 33.25 | 30.83 | 28.26 | 24.21 | 20.37 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 33.25 | 30.83 | 28.26 | 24.21 | 20.37 |
| Revenue From Operations / Share (Rs.) | 36.51 | 33.97 | 38.23 | 36.73 | 31.86 |
| PBDIT / Share (Rs.) | 5.68 | 6.04 | 8.09 | 7.59 | 5.24 |
| PBIT / Share (Rs.) | 4.77 | 5.12 | 7.22 | 6.65 | 4.24 |
| PBT / Share (Rs.) | 4.15 | 4.67 | 6.86 | 6.35 | 3.98 |
| Net Profit / Share (Rs.) | 3.17 | 3.50 | 5.08 | 4.78 | 2.97 |
| NP After MI And SOA / Share (Rs.) | 3.17 | 3.50 | 5.08 | 4.78 | 2.97 |
| PBDIT Margin (%) | 15.55 | 17.76 | 21.17 | 20.66 | 16.43 |
| PBIT Margin (%) | 13.06 | 15.08 | 18.87 | 18.10 | 13.30 |
| PBT Margin (%) | 11.35 | 13.73 | 17.95 | 17.27 | 12.48 |
| Net Profit Margin (%) | 8.67 | 10.30 | 13.29 | 13.02 | 9.33 |
| NP After MI And SOA Margin (%) | 8.67 | 10.30 | 13.29 | 13.02 | 9.33 |
| Return on Networth / Equity (%) | 9.52 | 11.34 | 17.98 | 19.75 | 14.59 |
| Return on Capital Employeed (%) | 14.00 | 16.08 | 24.68 | 26.53 | 19.69 |
| Return On Assets (%) | 6.45 | 8.90 | 14.83 | 16.23 | 10.64 |
| Long Term Debt / Equity (X) | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Total Debt / Equity (X) | 0.21 | 0.07 | 0.07 | 0.05 | 0.15 |
| Asset Turnover Ratio (%) | 0.82 | 0.92 | 1.21 | 1.24 | 1.18 |
| Current Ratio (X) | 2.90 | 4.53 | 5.75 | 5.37 | 3.40 |
| Quick Ratio (X) | 1.62 | 2.57 | 2.98 | 2.64 | 1.72 |
| Inventory Turnover Ratio (X) | 2.16 | 0.94 | 1.45 | 1.49 | 1.84 |
| Dividend Payout Ratio (NP) (%) | 25.26 | 25.71 | 19.67 | 16.72 | 21.85 |
| Dividend Payout Ratio (CP) (%) | 19.62 | 20.40 | 16.77 | 13.96 | 16.37 |
| Earning Retention Ratio (%) | 74.74 | 74.29 | 80.33 | 83.28 | 78.15 |
| Cash Earning Retention Ratio (%) | 80.38 | 79.60 | 83.23 | 86.04 | 83.63 |
| Interest Coverage Ratio (X) | 9.11 | 13.20 | 23.02 | 25.04 | 19.89 |
| Interest Coverage Ratio (Post Tax) (X) | 6.08 | 8.65 | 15.46 | 16.78 | 12.30 |
| Enterprise Value (Cr.) | 894.31 | 1285.96 | 1216.71 | 1993.77 | 716.44 |
| EV / Net Operating Revenue (X) | 1.61 | 2.49 | 2.09 | 3.56 | 1.48 |
| EV / EBITDA (X) | 10.34 | 13.99 | 9.87 | 17.24 | 8.99 |
| MarketCap / Net Operating Revenue (X) | 1.48 | 2.47 | 2.07 | 3.55 | 1.41 |
| Retention Ratios (%) | 74.73 | 74.28 | 80.32 | 83.27 | 78.14 |
| Price / BV (X) | 1.62 | 2.72 | 2.80 | 5.39 | 2.21 |
| Price / Net Operating Revenue (X) | 1.48 | 2.47 | 2.07 | 3.55 | 1.41 |
| EarningsYield | 0.05 | 0.04 | 0.06 | 0.03 | 0.06 |
After reviewing the key financial ratios for AVT Natural Products Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.17. This value is below the healthy minimum of 5. It has decreased from 3.50 (Mar 24) to 3.17, marking a decrease of 0.33.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.17. This value is below the healthy minimum of 5. It has decreased from 3.50 (Mar 24) to 3.17, marking a decrease of 0.33.
- For Cash EPS (Rs.), as of Mar 25, the value is 4.08. This value is within the healthy range. It has decreased from 4.41 (Mar 24) to 4.08, marking a decrease of 0.33.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 33.25. It has increased from 30.83 (Mar 24) to 33.25, marking an increase of 2.42.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 33.25. It has increased from 30.83 (Mar 24) to 33.25, marking an increase of 2.42.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 36.51. It has increased from 33.97 (Mar 24) to 36.51, marking an increase of 2.54.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 5.68. This value is within the healthy range. It has decreased from 6.04 (Mar 24) to 5.68, marking a decrease of 0.36.
- For PBIT / Share (Rs.), as of Mar 25, the value is 4.77. This value is within the healthy range. It has decreased from 5.12 (Mar 24) to 4.77, marking a decrease of 0.35.
- For PBT / Share (Rs.), as of Mar 25, the value is 4.15. This value is within the healthy range. It has decreased from 4.67 (Mar 24) to 4.15, marking a decrease of 0.52.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.17. This value is within the healthy range. It has decreased from 3.50 (Mar 24) to 3.17, marking a decrease of 0.33.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.17. This value is within the healthy range. It has decreased from 3.50 (Mar 24) to 3.17, marking a decrease of 0.33.
- For PBDIT Margin (%), as of Mar 25, the value is 15.55. This value is within the healthy range. It has decreased from 17.76 (Mar 24) to 15.55, marking a decrease of 2.21.
- For PBIT Margin (%), as of Mar 25, the value is 13.06. This value is within the healthy range. It has decreased from 15.08 (Mar 24) to 13.06, marking a decrease of 2.02.
- For PBT Margin (%), as of Mar 25, the value is 11.35. This value is within the healthy range. It has decreased from 13.73 (Mar 24) to 11.35, marking a decrease of 2.38.
- For Net Profit Margin (%), as of Mar 25, the value is 8.67. This value is within the healthy range. It has decreased from 10.30 (Mar 24) to 8.67, marking a decrease of 1.63.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.67. This value is within the healthy range. It has decreased from 10.30 (Mar 24) to 8.67, marking a decrease of 1.63.
- For Return on Networth / Equity (%), as of Mar 25, the value is 9.52. This value is below the healthy minimum of 15. It has decreased from 11.34 (Mar 24) to 9.52, marking a decrease of 1.82.
- For Return on Capital Employeed (%), as of Mar 25, the value is 14.00. This value is within the healthy range. It has decreased from 16.08 (Mar 24) to 14.00, marking a decrease of 2.08.
- For Return On Assets (%), as of Mar 25, the value is 6.45. This value is within the healthy range. It has decreased from 8.90 (Mar 24) to 6.45, marking a decrease of 2.45.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.21. This value is within the healthy range. It has increased from 0.07 (Mar 24) to 0.21, marking an increase of 0.14.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.82. It has decreased from 0.92 (Mar 24) to 0.82, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 2.90. This value is within the healthy range. It has decreased from 4.53 (Mar 24) to 2.90, marking a decrease of 1.63.
- For Quick Ratio (X), as of Mar 25, the value is 1.62. This value is within the healthy range. It has decreased from 2.57 (Mar 24) to 1.62, marking a decrease of 0.95.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.16. This value is below the healthy minimum of 4. It has increased from 0.94 (Mar 24) to 2.16, marking an increase of 1.22.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 25.26. This value is within the healthy range. It has decreased from 25.71 (Mar 24) to 25.26, marking a decrease of 0.45.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 19.62. This value is below the healthy minimum of 20. It has decreased from 20.40 (Mar 24) to 19.62, marking a decrease of 0.78.
- For Earning Retention Ratio (%), as of Mar 25, the value is 74.74. This value exceeds the healthy maximum of 70. It has increased from 74.29 (Mar 24) to 74.74, marking an increase of 0.45.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 80.38. This value exceeds the healthy maximum of 70. It has increased from 79.60 (Mar 24) to 80.38, marking an increase of 0.78.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 9.11. This value is within the healthy range. It has decreased from 13.20 (Mar 24) to 9.11, marking a decrease of 4.09.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.08. This value is within the healthy range. It has decreased from 8.65 (Mar 24) to 6.08, marking a decrease of 2.57.
- For Enterprise Value (Cr.), as of Mar 25, the value is 894.31. It has decreased from 1,285.96 (Mar 24) to 894.31, marking a decrease of 391.65.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.61. This value is within the healthy range. It has decreased from 2.49 (Mar 24) to 1.61, marking a decrease of 0.88.
- For EV / EBITDA (X), as of Mar 25, the value is 10.34. This value is within the healthy range. It has decreased from 13.99 (Mar 24) to 10.34, marking a decrease of 3.65.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.48. This value is within the healthy range. It has decreased from 2.47 (Mar 24) to 1.48, marking a decrease of 0.99.
- For Retention Ratios (%), as of Mar 25, the value is 74.73. This value exceeds the healthy maximum of 70. It has increased from 74.28 (Mar 24) to 74.73, marking an increase of 0.45.
- For Price / BV (X), as of Mar 25, the value is 1.62. This value is within the healthy range. It has decreased from 2.72 (Mar 24) to 1.62, marking a decrease of 1.10.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.48. This value is within the healthy range. It has decreased from 2.47 (Mar 24) to 1.48, marking a decrease of 0.99.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in AVT Natural Products Ltd:
- Net Profit Margin: 8.67%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 14% (Industry Average ROCE: 11.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.52% (Industry Average ROE: 11.17%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 6.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.62
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 20.1 (Industry average Stock P/E: 20.18)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.21
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.67%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agricultural Products | 60, Rukmani Lakshmipathy Salai, Chennai (Madras) Tamil Nadu 600008 | avtnpl@avtnatural.com http://www.avtnatural.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ajit Thomas | Chairman |
| Mr. A D Bopana | Director |
| Mrs. Shanthi Thomas | Director |
| Mrs. Kavitha Vijay | Director |
| Mr. M M Venkatachalam | Director |
| Mr. Ranganath N Krishna | Director |
| Mr. Rahul Thomas | Director |
FAQ
What is the intrinsic value of AVT Natural Products Ltd?
AVT Natural Products Ltd's intrinsic value (as of 06 November 2025) is 53.31 which is 25.75% lower the current market price of 71.80, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 1,094 Cr. market cap, FY2025-2026 high/low of 85.3/51.0, reserves of ₹491 Cr, and liabilities of 747 Cr.
What is the Market Cap of AVT Natural Products Ltd?
The Market Cap of AVT Natural Products Ltd is 1,094 Cr..
What is the current Stock Price of AVT Natural Products Ltd as on 06 November 2025?
The current stock price of AVT Natural Products Ltd as on 06 November 2025 is 71.8.
What is the High / Low of AVT Natural Products Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of AVT Natural Products Ltd stocks is 85.3/51.0.
What is the Stock P/E of AVT Natural Products Ltd?
The Stock P/E of AVT Natural Products Ltd is 20.1.
What is the Book Value of AVT Natural Products Ltd?
The Book Value of AVT Natural Products Ltd is 33.2.
What is the Dividend Yield of AVT Natural Products Ltd?
The Dividend Yield of AVT Natural Products Ltd is 0.97 %.
What is the ROCE of AVT Natural Products Ltd?
The ROCE of AVT Natural Products Ltd is 12.8 %.
What is the ROE of AVT Natural Products Ltd?
The ROE of AVT Natural Products Ltd is 9.89 %.
What is the Face Value of AVT Natural Products Ltd?
The Face Value of AVT Natural Products Ltd is 1.00.